Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Bergur V. Stefánsson | Researchclopedia

Back to researchers

Bergur V. Stefánsson

Gentofte Hospital ORCID

83

Works

9,588

Citations

33

h-index

49

i10-index

Research Topics

Diabetes Treatment and Management Chronic Kidney Disease and Diabetes Pancreatic function and diabetes

Affiliations

AstraZeneca (United Kingdom)2020–2020

Reykjavík University2016–2016

University Medical Center Groningen2020–2020

Sahlgrenska University Hospital1999–2000

Gentofte Hospital2021–2022

Top Works

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J.L. Heerspink,Bergur V. Stefánsson,et al.

20204,911 citations

Diabetes Management and Research

Metabolism, Diabetes, and Cancer

Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

David C. Wheeler,Bergur V. Stefánsson,et al.

2020511 citations

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

David C. Wheeler,Robert D. Toto,et al.

2021376 citations

Intradialytic Hypotension and Risk of Cardiovascular Disease

Bergur V. Stefánsson,Steven M. Brunelli,et al.

2014324 citations

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Hiddo J.L. Heerspink,Bergur V. Stefánsson,et al.

2019214 citations

Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial

Carol A. Pollock,Bergur V. Stefánsson,et al.

2019197 citations

Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

Niels Jongs,Tom Greene,et al.

2021192 citations

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

David C. Wheeler,Bergur V. Stefánsson,et al.

2020183 citations

Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

Hiddo J.L. Heerspink,Niels Jongs,et al.

2021182 citations